China Mobile Reports October 2024 Customer Growth - TipRanks
| 688656 Stock | 101.27 0.96 0.94% |
About 55% of HOB Biotech's investors are presently thinking to get in. The analysis of overall sentiment of trading HOB Biotech Group stock suggests that some investors are interested at this time. The current market sentiment, together with HOB Biotech's historical and current headlines, can help investors time the market. In addition, many technical investors use HOB Biotech Group stock news signals to limit their universe of possible portfolio assets.
HOB |
China Mobile Reports October 2024 Customer Growth TipRanks
Read at news.google.com
 |
HOB Biotech Fundamental Analysis
We analyze HOB Biotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of HOB Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of HOB Biotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Price To Book
Price To Book Comparative Analysis
HOB Biotech is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
HOB Biotech Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with HOB Biotech stock to make a market-neutral strategy. Peer analysis of HOB Biotech could also be used in its relative valuation, which is a method of valuing HOB Biotech by comparing valuation metrics with similar companies.
Peers
HOB Biotech Related Equities
| 601398 | Industrial | 0.62 | ||||
| 601988 | Bank of China | 0.57 | ||||
| 600036 | China Merchants | 0.29 | ||||
| 600519 | Kweichow Moutai | 0.34 | ||||
| 601628 | China Life | 0.81 | ||||
| 601939 | China Construction | 0.82 | ||||
| 601857 | PetroChina | 0.95 | ||||
| 601288 | Agricultural Bank | 1.18 | ||||
| 600941 | China Mobile | 2.15 | ||||
| 300750 | Contemporary Amperex | 2.62 |
Complementary Tools for HOB Stock analysis
When running HOB Biotech's price analysis, check to measure HOB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HOB Biotech is operating at the current time. Most of HOB Biotech's value examination focuses on studying past and present price action to predict the probability of HOB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HOB Biotech's price. Additionally, you may evaluate how the addition of HOB Biotech to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |